Parkin D., Whelan S., Ferlay J., Raymond LJYCancer Incidence in Five Continents: IARC Scientific Publications No. 155; 2002.
2.
Globocan2000. IARC CancerBase no. 5, software on CD-ROM. Lyon, France: International Agency for Research on Cancer; 2001.
3.
Møller B., Fekjaer H., Hakulinen T., Tryggvadottir L., Storm HH, Talbäck M., et al. Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer Prev2002;11(Suppl 1):1—96.
4.
Lichtenstein P., Holm NV, Verkasalo PK, Iliadou A., Kaprio J., Koskenvuo M., et al. Environmental and heritable factors in the causation of cancer — analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med2000;343:7880.
5.
Berrino F., Capocaccia R., Coleman MP, Esteve J., Gatta G., Hakulinen T., et al. Survival of Cancer Patients in Europe: the EUROCARE-3 Study ; 2003.
6.
Cancer Incidence in Sweden2003. Stockholm: Centre for Epidemiology, National Board of Health and Welfare. Socialstyrelsen; 2003.
7.
Talbäck M. , Stenbeck M., Rosén M., Barlow L., Glimelius B.Cancer survival in Sweden 1960—1998 — developments across four decades. Acta Oncol2003;42:637—59.
8.
Barlow L., Holmberg L.Krav på snabbare rapportering till Cancerregistret, enligt ny föreskrift . Läkartidningen2003;100:3152—4.
9.
Talbäck M. , Rosén M., Stenbeck M., Dickman PWCancer patient survival in Sweden at the beginning of the third millennium — predictions using period analysis. Cancer Causes Control2004;15:967—76.
10.
Ludwig H.Optimum cancer care — an unaffordable goal?Lancet Oncol2004;5:529—30.
11.
Collaborative Group on Hormonal Factors in Breast Cancer.Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease . Lancet2002;360: 187—95.
12.
Ziegler RG, Hoover RN, Pike MC, Hildesheim A., Nomura AM, West DW, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst1993;85:1819—27.
13.
Moradi T.Födelselandets betydelse. En rapport om hälsan hos olika invandrargrupper i Sverige (Significance of country of birth. Report on the health status of various groups of immigrants in Sweden): Statens Folkhälsoinstitut2002:29; 2002 .
14.
von Schoultz B., Bergkvist L., Magnusson C., von Schoultz E.Något förhöjd cancerrisk, men sambanden fortfarande oklara (Somewhat higher cancer risks but theconnections still diffuse). Läkartidningen2000;97:2225—6.
15.
Andersen A., Barlow L., Engeland A., Kjaerheim K., Lynge E., Pukkala E.Work-related cancer in the Nordic countries . Scand J Work Environ Health1999;25(Suppl 2):1—116.
16.
Ross R., Schottenfield E.Prostate cancer. In: Schottenfield D, Fraumeni J, editors. Cancer epidemiology and prevention. 2nd ed. New York : Oxford University Press; 1996. p. 1180—206.
17.
Olsen JH, et al. Avoidable cancers in the Nordic countries. APMIS, 105(76); 1997.
18.
Pershagen G., Axelson O., Damber L., Lagarde F., Svartengren M., Swedjemark GARadon i bostäder. Rökning ger mer än additiv riskökning (Radon in dwellings. Smoking gives more than an additive risk increase) . Läkartidningen1994;91:4628—32.
19.
Miljöhälsorapport 2001 (Environmental Health Report 2001, National Board of Health and Welfare). Stockholm: Socialstyrelsen; 2001 .
20.
National Radiation Protection Board (NRPB).Board Statement on Effects of Ultraviolet Radiation to Human Health: NRPB; 1995.
21.
De Vries E.Trends and risk factors of cutaneous melanoma in Europe. Rotterdam, Holland: Erasmus University; 2004.
